Compare Sumber Energi Andalan Tbk (ITMA) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sumber Energi Andalan Tbk vs Organon Pharma Indonesia Tbk. — how do they compare? Sumber Energi Andalan Tbk trades at Rp1,530 (market cap 1.53T, 61.1K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Sumber Energi Andalan Tbk is far larger — about 14.7× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| ITMA | SCPI | |
|---|---|---|
Market Cap | 1.53T | 104.4B |
Volume | 61.1K | — |
Lot | 611 | — |
Turnover | 94.72M | — |
Average Price | 1,550.26 | — |
Value | 94.72M | — |
Indicative Equilibrium Price | 1,530 | — |
Indicative Equilibrium Volume | 5 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sumber Energi Andalan Tbk
PT Sumber Energi Andalan Tbk (the Company) was established based on Notarial deed No. 6 dated September 21, 2011 of Leolin Jayayanti, S.H., notary in Jakarta. PT Sumber Energi Andalan Tbk manufactures gold jewelry such as necklaces, bracelets, rings, and pendants. The company has a factory located on a site of 18.3 Ha in the industrial estate Rungkut, Surabaya. Previously the Company's name had been changed from PT Itamaraya Gold Industry Tbk to PT Itamaraya Tbk.
Read more on ITMA →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
